Literature DB >> 8713658

Deficient quantitative expression of CD45 isoforms on CD4+ and CD8+ T cell subpopulations and subsets of CD45RA(low)CD45RO(low) T cells in newborn blood.

S Chheda1, K H Palkowetz, D K Rassin, A S Goldman.   

Abstract

Deficiencies in the quantitative expression of CD45RA and CD45RO on CD4+ and CD8+ T cells and in a population of CD45RA(low)CD45RO(low) T cells in blood from term newborn infants were found by flow cytometry. The relative frequencies of CD45RO on CD4+ T cells from adults and newborn infants were 72 and 58%, respectively. However, in newborn infants greater than 70% of T cells expressing CD45RO also expressed CD45RA. In addition, the quantitative expression of CD45RA and CD45RO on newborn T cells was significantly less than that found on adult blood T cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8713658     DOI: 10.1159/000244287

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  5 in total

1.  Programmed cell death (apoptosis) in cord blood lymphocytes.

Authors:  S Aggarwal; A Gupta; S Nagata; S Gupta
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

2.  Function and phenotype of immature CD4+ lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers.

Authors:  K C Rich; J N Siegel; C Jennings; R J Rydman; A L Landay
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

3.  Evolution of the mammary gland defense system and the ontogeny of the immune system.

Authors:  Armond S Goldman
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-07       Impact factor: 2.673

Review 4.  Growth hormone and prolactin--molecular and functional evolution.

Authors:  Isabel A Forsyth; Michael Wallis
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-07       Impact factor: 2.673

5.  Costimulation of naive CD8(+) lymphocytes induces CD4 expression and allows human immunodeficiency virus type 1 infection.

Authors:  S G Kitchen; Y D Korin; M D Roth; A Landay; J A Zack
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.